News | January 12, 2009

Cardima to Exhibit, Host Symposium at 45th Annual STS Meeting

January 13, 2009 - Cardima Inc. plans to showcase its atrial fibrillation treatment products and technologies at the 45th Annual Meeting of the Society of Thoracic Surgeons (STS) conference Jan. 26-28, 2009 in San Francisco.

Cardima will also sponsor a breakfast symposium at the STS conference entitled, "Surgical Ablation - Keys to Success." The symposium will highlight Cardima's Surgical Ablation System and feature prominent speakers including:

- Li Poa, M.D., FACS, chief of Cardiothoracic Surgery and Cardiac Surgery Program Director at Stamford Hospital and faculty member of Columbia University. Dr. Poa is among the world's leading authorities on surgical ablation for the treatment of atrial fibrillation (AF) and is head of the Cardima Center of Excellence and Training Program at Stamford Hospital. He has conducted extensive work perfecting thoracoscopic surgical techniques, and will train cardiothoracic surgeons in the use of the Cardima Surgical Ablation System.

- Sanjeev Saksena, M.D., FHRS, FACC, FESC FAHA, clinical professor of Medicine, Robert Wood Johnson School of Medicine and medical director of the Electrophysiology Research Foundation. Dr. Saksena was the director of the Cardiovascular Institute, Atlantic Health System (Eastern Campus) from 1999-2004 and is a past president of the North American Society of Pacing and Electrophysiology (NASPE). He is the founding editor and current editor-in-chief of the Journal of Interventional Cardiac Electrophysiology. Dr. Saksena is also a Planning/Steering Committee member of the National Institute of Health AFFIRM & TOPCAT trials that have focused on atrial fibrillation.

The Surgical Ablation System uses Cardima's patented technology for the ablation of cardiac tissue. The system incorporates a microcatheter-based surgical probe coupled with Cardima's INTELLITEMP, a radiofrequency energy management device. The probe incorporates irrigation, suction and illumination, which aid in placement and lesion depth. The Cardima Surgical Ablation System is reportedly able to create deep, long, linear and transmural cardiac lesions without gaps, and the small, flexible design offers sole port-hole access, potentially decreasing procedure time, patient hospital stay and discomfort.

The breakfast symposium will be held at the San Francisco Marriott on Jan. 27 at 6:00 a.m. For additional details, please contact Dilyana Hadjeva at [email protected] About Cardima Surgical Ablation System

For more information:

Related Content

Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Sponsored Content | Videos | Atrial Fibrillation| May 17, 2017
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopk
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems| May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
The Arctic Front Advance Cardiac CryoAblation Catheter treats atrial fibrillation with pulmonary vein isolation
News | Atrial Fibrillation| April 11, 2017
April 10, 2017 — Medtronic recently announced the first enrollments in the STOP Persistent AF clinical trial.
Overlay Init